Apotex Corp. 2026-03-25 Health serious FDA
Health · FDA · Recall #FDA-D-0407-2026
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only,… Recall
Issued March 25, 2026 · Apotex Corp.
In March 2026, Apotex Corp. recalled the Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility
What you should do
- 1 Stop using Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Apotex Corp. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Apotex Corp.
- Category
- Health
- Recall date
- March 25, 2026
- Units affected
- Not reported
- Sold at
- U.S. Nationwide
- Recall number
- FDA-D-0407-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Apotex Corp. has 9 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.